Chromogenic Factor VIII Assay

The Thrombosis and Hemostasis Summit of North America (THSNA) convenes in Chicago Thursday, April 23 to Saturday April 25. Fritsma Factor’s sponsor, Precision BioLogic Inc, Halifax, NS, and Affinity Biologicals, Inc,Toronto, ON will occupy booth 401. From 5:45 to 6:30 on Thursday, presenters will be located near their posters including the following posters developed by […]

Comments (0)

Bleeding Disorders

Feb 24 2020

george

Hex-phase Phospholipid Reagent

The Thrombosis and Hemostasis Summit of North America (THSNA) convenes in Chicago Thursday, April 23 to Saturday April 25. Fritsma Factor’s sponsor, Precision BioLogic Inc, Halifax, NS, and Affinity Biologicals, Inc,Toronto, ON will occupy booth 401. From 9:45 to 10:30 on Thursday, presenters will be located near their posters including the following poster developed by […]

Events

Coumadin Therapy: Molecular Screens?

George is preparing updates for several of our Educational Modules and is currently revising the Coumadin (Warfarin) module of the Antithrombotic Therapy series. While DOAC therapy is rapidly replacing Coumadin as the mainstay for stroke prevention in non-valvular atrial fibrillation and for prophylaxis following total hip and knee replacement surgery, Coumadin is still in everyday […]

Comments (0)

Anticoagulant Therapy

Feb 1 2020

george

PBI Innovative Business Award

Congratulations to my sponsor, Precision BioLogic Inc. for their prestigious Innovative Business of the Year award presented at the Halifax annual Halifax Business Awards Ceremony. The award in part was presented based on their 2019 CRYOcheck Factor VIII Inhibitor Kit launch. Click or tap here for details, and congratulations to the PBI “crew.”

Events

QQ: Chronic Bleeds, Normal PT and PTT

For our February, 2020 Quick Question we ask, “a 34-YO woman who experiences chronic bleeding and poor wound healing has normal PT, PTT, fibrinogen, and platelet results, including platelet function testing. What test should be performed next?” Please provide your answer and post comments here using the comment function or by emailing George ([email protected]).

Comments (0)

Quick Question Archive

Jan 30 2020

george

QQ Results: 5 YO Girl with Systemic Bleeding

Our January, 2020 Quick Question was based on our December 26, 2019 case, 5 YO Girl with Systemic Bleeding. This case generated discussion from experts around the world, whose comments are provided below. But first, here is the question and responses. Question: What diagnosis fits no aggregation reponse to ADP, collagen, and AA? The question […]

Bleeding Disorders

New Chromogenic Factor VIII Assay

In a January 20, 2020 press release, Fritsma Factor sponsor Precision BioLogic Inc. announced the availability of its new CRYOcheck Chromogenic Factor VIII assay in Canada, the European Union, Australia, and New Zealand following market authorization by Health Canada and the respective in-country regulatory authorities. This assay offers a test range from 0–200% FVIII using […]

Bleeding Disorders

More on D-dimer Reporting

Continuing in our D-dimer discussion, click or tap to read “Raising D-dimer Threshold Cuts Need for Chest Imaging by 30% in Suspected Pulmonary Embolism.” This article appears in the January/February issue of Clinical Laboratory News and refers to Kearon C, de Wit K, Parpia S, et al. Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to […]

Fibrinolysis

D-dimer Reporting Issues

Click or tap here for a January, 2020 Karen Titus CAP Today feature article on concerns around D-dimer assay reporting. The article focuses on unit variation, including FEUs versus DDUs, appropriate usage in ruling out DVT and PE, and emergency department turn-around times. Contributors include Kristin Lundy, MLS, Vermont; Drs. Andrew Goodwin, Vermont; Karen Moser, […]

Fibrinolysis

HCT >55%

Click or tap this December, 2019 CAP Today “Best of Q&A” series answer to “Should a patient with a hematocrit greater than 55 percent be redrawn for correction always or only when prothrombin time and partial prothrombin time are elevated?” A shout out to Andrew Goodwin IV, MD, Department of Pathology, University of Vermont College […]

Comments (0)

Specimen Management

All Posts

Chromogenic Factor VIII Assay

Hex-phase Phospholipid Reagent

Coumadin Therapy: Molecular Screens?

PBI Innovative Business Award

QQ: Chronic Bleeds, Normal PT and PTT

QQ Results: 5 YO Girl with Systemic Bleeding

New Chromogenic Factor VIII Assay

More on D-dimer Reporting

D-dimer Reporting Issues

HCT >55%

George Fritsma MS MLS

Cheat Sheets from George

Questions or Comments?

Quick Question